Q32 Bio Inc.QTTBEarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Q32 Bio Inc. is a clinical-stage biotechnology company focused on developing targeted antibody-based immunotherapies for autoimmune disorders, inflammatory conditions and rare immunological diseases with unmet medical needs, operating primarily across North America and European markets.